Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Ejaculatory Anhedonia

Pleasure-dissociative orgasmic disorder, orgasm without pleasure

Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
No FDA-approved treatment; management targets reversible causes

Reference only. Not medical advice.

What can go wrong

The condition is distressing and easily conflated with low libido, delayed ejaculation, or depression itself. The main actionable step is identifying reversible causes, reviewing serotonergic medications, checking prolactin and testosterone, and screening for mood disorder, before assuming the problem is fixed. No drug is approved for it; treatment is cause-directed and often trial-and-error.

This is something to take to a clinician. The Atlas can tell you what is known about ejaculatory anhedonia in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Ejaculatory or sexual anhedonia (also called pleasure-dissociative orgasmic disorder, PDOD) is the inability to feel the pleasure normally associated with orgasm even though the physical events, ejaculation, muscular contractions, occur normally. It is rare and poorly studied. Proposed contributors include reduced dopaminergic signaling, elevated prolactin, low testosterone, depression and anxiety, spinal cord injury, and medications, SSRIs in particular are repeatedly implicated.

The body climaxes, but the pleasure never arrives.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Recognition of a distinct orgasmic complaint separate from delayed ejaculation or low libido

How it is supposed to work

Orgasmic pleasure is thought to depend on dopaminergic reward circuitry; anhedonia is hypothesized to reflect a disconnect between genital sensory input and the brain's recognition of that input as pleasurable. Excess prolactin and serotonergic tone (as with SSRIs) dampen this pathway, while low testosterone may blunt it further. Because mechanisms overlap with depression and drug effects, careful history is essential.

Safety in detail

Assessment may involve prolactin and testosterone testing and medication adjustment, which require physician oversight. Do not stop prescribed antidepressants abruptly to chase pleasure recovery; discuss changes with a clinician.

What people get wrong

  • Often saidAnhedonia is the same as not being able to orgasm

    ActuallyNo, the orgasm and ejaculation still happen; what is missing is the pleasure. This distinguishes it from anorgasmia and delayed ejaculation.

  • Often saidIt is purely psychological

    ActuallyHormonal (prolactin, testosterone), neurochemical (dopamine), and medication-related causes are documented and should be assessed, not just psychological ones.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

At a glance

Core feature
Normal ejaculation, absent pleasure
Implicated neurochemistry
Low dopamine, high prolactin
Common drug trigger
SSRIs
Other contributors
Low testosterone, depression, spinal injury

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Ejaculatory Anhedonia. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.
  • Where we land. We have not taken a position on this yet.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • Clinical descriptions of sexual/orgasmic anhedoniavarious

    Characterize PDOD as a rare disorder with preserved orgasmic physiology but absent subjective pleasure, frequently linked to dopaminergic and prolactin disturbance